Literature DB >> 15893280

Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.

G Maconi1, E Colombo, P Zerbi, G M Sampietro, P Fociani, M Bosani, A Cassinotti, V Casini, A Russo, S Ardizzone, M Porta, G Bianchi Porro.   

Abstract

OBJECTIVE: To determine the prevalence of cytomegalovirus infection in patients with steroid-refractory ulcerative colitis who required colonic resection, and to assess its possible association with the use of immunosuppressive and steroid treatment and outcome after colectomy. PATIENTS AND METHODS: The study included surgical specimens and related pre-operative endoscopic biopsy specimens of 77 consecutive ulcerative colitis patients (34 females) who underwent colectomy because of intractable steroid-refractory ulcerative colitis (55 patients), toxic megacolon (6 patients), dysplasia or cancer (7 patients) or loss of function of the colon (9 patients). Clinical features and current and past treatments were analysed. Haematoxylin and eosin and specific immunohistochemical staining for cytomegalovirus were used to detect inclusion bodies in all specimens.
RESULTS: Cytomegalovirus infection was found in 15 of 55 steroid-refractory ulcerative colitis patients (27.3%) and in 2 of 22 non-refractory patients (9.1%) (p=0.123). Only six patients had positive staining for cytomegalovirus in pre-operative endoscopic biopsy specimens. Detection of cytomegalovirus inclusion in biopsy specimens was not related to the number of biopsies or to time that had elapsed since colonoscopy and index surgery. Cytomegalovirus-positive patients were more likely to be on systemic corticosteroids (p=0.03). In contrast, current use and duration of immunosuppressive treatment, number of steroid cycles since diagnosis and in the last year, as well as chronic use of steroid in the last year were not significantly related to cytomegalovirus infection. Cytomegalovirus-positive patients did not receive antiviral therapy following proctocolectomy but did not show endoscopic or histological cytomegalovirus reactivation in the ileo-anal pouch and in the remaining bowel.
CONCLUSIONS: Cytomegalovirus infection is frequently found in surgical specimens of patients with steroid-refractory ulcerative colitis and is more likely in patients on corticosteroid treatment. Cytomegalovirus infection is frequently unrecognised in pre-operative biopsy specimens, thus raising concerns about the accuracy of the available diagnostic tools. Unrecognised and untreated cytomegalovirus infection does not affect the outcome of ulcerative colitis patients following proctocolectomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893280     DOI: 10.1016/j.dld.2005.01.011

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  24 in total

Review 1.  Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease.

Authors:  Josep Bassaganya-Riera; Raquel Hontecillas
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-09       Impact factor: 4.294

2.  Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital.

Authors:  Raed Al-Zafiri; Adrian Gologan; Polymnia Galiatsatos; Andrew Szilagyi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

3.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

4.  Cytomegalovirus, inflammatory bowel disease, and anti-TNFα.

Authors:  Sara T Campos; Francisco A Portela; Luís Tomé
Journal:  Int J Colorectal Dis       Date:  2017-01-13       Impact factor: 2.571

5.  Cytomegalovirus infection in patients who required colectomy for toxic megacolon or severe steroid-refractory ulcerative colitis.

Authors:  J Barahona-Garrido; B Martínez-Benítez; E Espinosa-Cárdenas; H M Sarti; J I Gutiérrez-Manjarrez; R Aguirre-Gutiérrez; F I Tellez-Avila; E Coss-Adame; I García-Juárez; J K Yamamoto-Furusho
Journal:  Dig Dis Sci       Date:  2010-03       Impact factor: 3.199

6.  Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Authors:  Minh Nguyen; Kara Bradford; Xiaolan Zhang; David Q Shih
Journal:  Ulcers       Date:  2011-01-01

Review 7.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 8.  Cytomegalovirus and inflammatory bowel disease: is there a link?

Authors:  Valeria Criscuoli; Maria-Rosa Rizzuto; Mario Cottone
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

9.  Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis.

Authors:  Nobin Babu Kalappurayil; Jino Thomas; Baburajan Mankuni; Varghese Thomas
Journal:  J Clin Diagn Res       Date:  2017-03-01

10.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.